Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • ACA Enrollment
  • Ebola
  • PFAS in Drinking Water
  • Drug-Related Driving Deaths
  • Black Maternal Health

WHAT'S NEW

  • ACA Enrollment
  • Ebola
  • PFAS in Drinking Water
  • Drug-Related Driving Deaths
  • Black Maternal Health

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Tuesday, Sep 11 2018

Full Issue

Doctors Are So Ill-Trained To Fight Opioid Crisis Experts Say It's Like 'Trying To Fight World War II With Only Coast Guard'

There has been little addiction training in medical schools across the country, but a decades-long push may be changing that.

The New York Times: Most Doctors Are Ill-Equipped To Deal With The Opioid Epidemic. Few Medical Schools Teach Addiction.

To the medical students, the patient was a conundrum. According to his chart, he had residual pain from a leg injury sustained while working on a train track. Now he wanted an opioid stronger than the Percocet he’d been prescribed. So why did his urine test positive for two other drugs — cocaine and hydromorphone, a powerful opioid that doctors had not ordered? (Hoffman, 9/10)

And in other news on the epidemic —

Reuters: Orexo Soars After Winning Opioid Drug Appeal Against Teva

A U.S. appeals court on Monday revived Swedish pharmaceutical company Orexo AB's lawsuit accusing a unit of Israel's Teva Pharmaceutical Industries Ltd of infringing a patent for its opioid addiction drug Zubsolv. Shares of Orexo closed 30.9 percent higher in Stockholm after the decision by the U.S. Federal Circuit Court of Appeals in Washington, D.C., which handles intellectual property cases. (Stempel, 9/10)

The Tennessean: Tennessee’s Pill Addiction Is Improving, But Fentanyl Looms

It’s a little hard to tell, but Tennessee may be turning a corner on prescription pill abuse. Although fatal opioid overdoses continue to rise throughout the state, deaths attributed specifically to prescription painkillers dropped for the first time in five years. The 12 percent decrease in 2017 is a rare sign of progress in a state ravaged by addiction. (Kelman, 9/10)

The Associated Press: Meth Use Makes Comeback In Colorado As Opioid Epidemic Worsens

Recent data shows methamphetamine use made a deadly comeback across Colorado last year. Figures from the Colorado Department of Public Health and Environment show meth ranked among the fastest-growing drugs in fatalities in the state from 2016 to 2017. (9/10)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, May 19
  • Monday, May 18
  • Friday, May 15
  • Thursday, May 14
  • Wednesday, May 13
  • Tuesday, May 12
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF